Drawing for CELLCITY SCOUT AI

USPTO serial 79370334

CELLCITY SCOUT AI

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
MESSICK, TABITHA LEE
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLCITY SCOUT AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biological, chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, dyes and labels, molecular probes, buffers, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic particles, column materials; reagents and solvents for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers, in particular nucleic acids, enzymes, proteins, macromolecules and biologically active substances; kits containing biological, chemical, biochemical and/or biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells as well as for performing labeling, separation, isolation, purification, amplification and/or analysis methods for biopolymers, in particular nucleic acids, enzymes, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample materialSECTION 70 - CANCELLED—
005Diagnostics, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular and metabolic diseases; products for human medical and/or veterinary purposes, namely, chemical, biological, biochemical, biotechnological and/or pharmaceutical products, enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, components and lysates thereof; cultures of microorganisms as well as cell cultures; diagnostics human medical and/or veterinary purposes, in particular nucleic acids, enzymes, polymerases, dyes and labels, molecular probes, buffers, aqueous and non- aqueous solutions of alcohols and/or salts, distilled or purified water, silicates, magnetic particles, column materials, biological, chemical, biochemical and biotechnological products; kits containing products for human medical or veterinary diagnostic purposes, in particular biological, chemical, biochemical and/or biotechnological products for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular enzymes, proteins, macromolecules and biologically active substancesSECTION 70 - CANCELLED—
009Computer hardware, software [recorded or downloadable] including application software, virtual and augmented reality software and mobile applications [apps], AI software (artificial intelligence software), media content, databases; the aforementioned goods in particular for use in bioinformatics, biology, biochemistry, biotechnology, chemistry, genetics, genetic engineering, pharmacy, medicine and medical diagnostics; bioinformatics software; scientific apparatus, instruments and devices, in particular microfluidic systems, cell culture plates, cell culture chips, microfluidic chips, biochips, nanoliter dispensing systems, vacuum pumps, chromatography columns, robots and automatized laboratory plants and spare parts and equipment therefor, in particular, preprogrammed cards, microplates, pipettes, pipette tips, pipette tip holders, test vessels, reagent holders, flasks, containers, test tube holders, holders for microvessels, magnetic particles, magnetic syringes, biochips, thermocyclers, homogenizers, vacuum valves; scientific apparatus, instruments and devices, in particular control units for controlling the aforementioned microfluidic systems; incubators or temperature chambers for laboratory purposes; systems comprising microfluidic systems, control units and/or incubators or temperature chambers; all the foregoing goods in particular for research, development and investigation purposes, as well as in particular for sample preparation, modification and manipulation of cells, as well as for labeling, separation, isolation, purification, amplification and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular proteins and/or nucleic acids from biological or biochemical sample materialSECTION 70 - CANCELLED—
010Devices for medical and veterinary purposes; diagnostic, examination and monitoring devices for medical and veterinary purposes, in particular cell culture devices for medical and veterinary purposes; artificial organs and implants; laboratory devices, measuring apparatuses and instruments for the use of products for medical or veterinary diagnostic purposes, in particular for the diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular and metabolic diseases as well as food diagnosticsSECTION 70 - CANCELLED—
042Scientific and technological services, in particular in the area of research, development and diagnostics in the field of chemistry, genetics, biology, biotechnology and biochemistry; diagnostic services in the field of DNA, RNA and protein detection and analysis, in particular in the field food diagnostics; design, development, programming, implementation, maintenance, updating, rental and customisation of software, in particular bioinformatics software, AI software (artificial intelligence software) and software for use in biology, biochemistry, biotechnology, chemistry, genetics, genetic engineering, medicine and medical diagnostics; software as a service [SaaS]; platform as a service [PaaS]; cloud computing; performing computer and software based analysis; computer hardware development; IT consultancy, advisory and information servicesSECTION 70 - CANCELLED—
044Diagnostic services in the field of DNA, RNA and protein detection and analysis, in particular in the field of diagnosis of infectious diseases, tumor diseases, allergies, autoimmune diseases, cardiovascular and metabolic diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 15, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 27, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 26, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 25, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 25, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 25, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 7, 2023RFNPREFUSAL PROCESSED BY IB—
Jul 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 13, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 8, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2023DOCKASSIGNED TO EXAMINER—
May 26, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance